From: Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study
Pt | Age (yrs) | Wt (kg) | FEV_{1} (%) | % HbA_{1c} at Dx | Rx Course (yrs) | Clinical Data |
---|---|---|---|---|---|---|
I_{1} | 28 | 65.8 | 56 | 5.5 | 4 | PI, Lupus^{N}, Deceased |
I_{2} | 31 | 65.3 | 44 | 14.3 | 2 | PI, Deceased |
I_{3} | 13 | 41.9 | 57 | 9.3 | 4 | PS |
I_{4} | 33 | 54.3 | 18 | 10.0 | 2 | PI, Deceased, RI* |
I_{5} | 14 | 49.0 | 99 | 10.9 | 8 | PI |
I_{6} | 44 | 81.5 | 30 | 9.2 | 5 | PI, Cor P, HTN, BPH |
I_{7} | 24 | 53.0 | 57 | 7.3 | 3 | PI, AIHS, RI |
I_{8} | 21 | 70.5 | 93 | 9.8 | 10 | PI |
S_{1} | 29 | 75.5 | 71 | 7.1 | 1 | PI |
S_{2} | 17 | 33.6 | 33 | 8.1 | 2 | PI, Deceased |
S_{3} | 25 | 73.9 | 48 | 7.8 | 4 | PI, Deceased |
S_{4} | 33 | 97.5 | 83 | 6.3 | 1 | PI, Bipolar, HTN |
S_{5} | 18 | 49.7 | 30 | 6.6 | 1 | PI, Deceased |
M_{1}I_{4} | 35 | 51.5 | 17 | 9.7 | 1 | PI |
M_{2} | 24 | 71.1 | 117 | 5.4 | 2 | PI |
M_{3}I_{5} | 22 | 68.5 | 68 | 9.6 | 2 | PI |
M_{4} | 19 | 70.0 | 100 | 6.1 | 3 | PI |
M_{5} | 22 | 67.7 | 88 | 13.3 | 3 | PI, Hepatic Cirrhosis |
M_{6} | 15 | 41.8 | 85 | 8.9 | 5 | PI |
T_{1} | 29 | 58.0 | 47 | 13.3 | 2 | PI |
T_{2} | 20 | 44.4 | 23 | 5.1 | 1 | PI |
T_{3}I_{6} | 49 | 85.5 | 29 | 9.2 | 2 | PI, Cor P, HTN, BPH |
T_{4}I_{7} | 32 | 55.7 | 65 | 7.3 | 2 | PI, AIHS, RI |
T_{5}S_{4} | 34 | 96.5 | 92 | 6.3 | 1 | PI, Bipolar, HTN |
T_{6} | 40 | 54.0 | 56 | 9.6 | 2 | PI, Lupus, RI ABPA |